BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9004953)

  • 1. High-performance liquid chromatographic assay for diltiazem in small-volume blood specimens and application to pharmacokinetic studies in rats.
    Scully P; Meehan E; Kelly JG
    J Chromatogr A; 1996 Apr; 729(1-2):297-300. PubMed ID: 9004953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPLC determination of diltiazem in human plasma and its application to pharmacokinetics in humans.
    Li K; Zhang X; Zhao F
    Biomed Chromatogr; 2003 Dec; 17(8):522-5. PubMed ID: 14648609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bioavailability of diltiazem in prolonged-release oral preparations.
    Quiroga PA; Yuln GV; Palummo M; Cingolani A; Dall LL; Volonté MG
    Drug Dev Ind Pharm; 2001 Nov; 27(10):1099-106. PubMed ID: 11794812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of diltiazem and desacetyldiltiazem in serum by high-performance liquid chromatography.
    Paczkowski D; Dabrowski R; Sitkiewicz D; Sadowski Z
    Pol J Pharmacol; 1995; 47(5):429-34. PubMed ID: 8868135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender related pharmacokinetics of diltiazem in healthy subjects.
    Sáenz-Campos D; Bayés MC; Martin S; Barbanoj MJ; Jané F
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):397-400. PubMed ID: 7582396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats.
    Choi JS; Han HK
    Int J Pharm; 2005 Nov; 305(1-2):122-8. PubMed ID: 16226412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic method for the assay of TA-3090 and its pharmacokinetic parameters in healthy volunteers.
    Lefebvre M; Garceau D; Spenard J; Houle JM; Major D; Caille G
    J Pharm Biomed Anal; 1989; 7(12):1919-24. PubMed ID: 2490584
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits.
    Choi JS; Li X
    Int J Pharm; 2005 Jun; 297(1-2):1-8. PubMed ID: 15907592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats.
    Hong SP; Choi DH; Choi JS
    Cardiovasc Ther; 2008; 26(4):269-75. PubMed ID: 19035878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of diltiazem in human whole blood and plasma by high-performance liquid chromatography using a polymeric reversed-phase column and utilizing a salting-out extraction procedure.
    Rustum AM
    J Chromatogr; 1989 May; 490(2):365-75. PubMed ID: 2768409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
    Li C; Choi JS
    Pharmazie; 2008 Nov; 63(11):815-8. PubMed ID: 19069242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HPLC determination of diltiazem in human serum and its pharmacokinetic parameters].
    Li K; Zhang X; Yuan Y; Luo N; Tan L
    Se Pu; 1997 Sep; 15(5):451-3. PubMed ID: 15739506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Cho YA; Choi DH; Choi JS
    J Pharm Pharmacol; 2009 Jun; 61(6):825-9. PubMed ID: 19505375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Hong SP; Chang KS; Choi DH; Choi JS
    Arch Pharm Res; 2007 Jan; 30(1):90-5. PubMed ID: 17328247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of diltiazem hydrochloride in human serum by high-performance liquid chromatography.
    Chaudhary RS; Gangwal SS; Avachat MK; Shah YN; Jindal KC
    J Chromatogr; 1993 May; 614(2):261-6. PubMed ID: 8314938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple and sensitive high-performance liquid chromatography assay of diltiazem and main metabolites in renal transplanted patients.
    Christensen H; Carlson E; Asberg A; Schram L; Berg KJ
    Clin Chim Acta; 1999 May; 283(1-2):63-75. PubMed ID: 10404732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of high performance liquid chromatography method for lacidipine in rabbit serum: application to pharmacokinetic study.
    Ramesh G; Vamshi Vishnu Y; Chinna Reddy P; Shravan Kumar Y; Madhusudan Rao Y
    Anal Chim Acta; 2009 Jan; 632(2):278-83. PubMed ID: 19110105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma. Application to pharmacokinetics.
    Goebel KJ; Kölle EU
    J Chromatogr; 1985 Dec; 345(2):355-63. PubMed ID: 4086603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phenobarbital pretreatment on the pharmacokinetics and metabolism of diltiazem in rats.
    Yeung PK; Buckley SJ; Cameron R; Feng JD; Jordan J
    Drug Metabol Drug Interact; 1996; 13(1):29-39. PubMed ID: 8902429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic analysis of diltiazem and its metabolite in plasma.
    Verghese C; Smith MS; Aanonsen L; Pritchett EL; Shand DG
    J Chromatogr; 1983 Jan; 272(1):149-55. PubMed ID: 6841534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.